Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Note:
FAQs about Glaxosmithkline Pharmaceuticals share price
Glaxosmithkline Pharmaceuticals is trading at 1939.00 as on Thu Mar 28 2024 09:59:50. This is 3.05% upper as compared to its previous closing price of 1881.70.
The market capitalization of Glaxosmithkline Pharmaceuticals is 32848.60 Cr as on Thu Mar 28 2024 09:59:50.
The average broker rating on Glaxosmithkline Pharmaceuticals is Hold. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 0 analysts have given a buy rating
- 2 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Glaxosmithkline Pharmaceuticals is 2649.95 whereas the 52 wk low is 1228.00
Glaxosmithkline Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 60.78
- Sector P/E: 31.31
- Dividend Yield: 1.64%
- D/E ratio: -
Glaxosmithkline Pharmaceuticals reported a net profit of 610.69 Cr in 2023.
Glaxosmithkline Pharmaceuticals Quick Links
Glaxosmithkline Pharmaceuticals Dividend | Glaxosmithkline Pharmaceuticals Bonus | Glaxosmithkline Pharmaceuticals News | Glaxosmithkline Pharmaceuticals AGM | Glaxosmithkline Pharmaceuticals Rights | Glaxosmithkline Pharmaceuticals Splits | Glaxosmithkline Pharmaceuticals Board Meetings | Glaxosmithkline Pharmaceuticals Key Metrics | Glaxosmithkline Pharmaceuticals Shareholdings | Glaxosmithkline Pharmaceuticals Profit Loss | Glaxosmithkline Pharmaceuticals Balance Sheet | Glaxosmithkline Pharmaceuticals Cashflow | Glaxosmithkline Pharmaceuticals Q1 Results | Glaxosmithkline Pharmaceuticals Q2 Results | Glaxosmithkline Pharmaceuticals Q3 Results | Glaxosmithkline Pharmaceuticals Q4 Results
Equity Quick Links
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks